Womens Health Problems - Oncologists states to overcome these womens health problems, with the provision of dual therapy in the form of radiotherapy and concurrent chemotherapy for breast cancer patients, can significantly reduce the risk of cancer grows back. It is considered as a new treatment approach to breast cancer worldwide. According to experts in the UK, dual therapy is known as synchronous chemoradiation is also able to save lives of people with breast cancer, a disease that has killed 425 000 women in one year throughout the world.
They say, synchronous treatment showed limited side effects and does not damage the quality of life of patients, so it should be considered for use by all physicians of breast cancer. "These results have implications worldwide," said Indrajit Fernando, consultant clinical oncologist at University Hospital Birmingham Trust, told reporters at the European Congress of Cancer Multidisciplinary (EMCC) in Stockholm.
As we all know these women's health problems, breast cancer is the most common cancer among women. A recent study by the Institute for Health Metrics and Evaluation in the United States found that, in 2010 breast cancer has killed about 425,000 people and was just diagnosed in 1.6 million. Radiotherapy and chemotherapy is usually given after breast cancer surgery to kill cancer cells remaining in the breast, chest wall or underarm area, and try to reduce the risk of local cancer recurrence. Meanwhile, the standard approach to chemotherapy is given first, followed by radiotherapy.
According to Fernando, during this time when the administration of radiotherapy and chemotherapy have long been debated among cancer experts, so the team decided to explore different schedules of radiotherapy with the type of chemotherapy called an anthracycline-CMF chemotherapy in patients with early stage breast cancer. The study involved nearly 2300 women in Britain who had undergone surgery to remove their tumors.
The results showed that, compared with the standard approach, giving both treatments at the same time may reduce the risk, return of local cancer recurrence of 35 percent of women with early breast cancer. After the development for eight years, the study found that only 41 patients in the chemoradiation group synchronous suffered relapses, compared with 63 patients in the group who had undergone standard chemotherapy followed by radiation treatment.
For five years, the cancer recurrence rate of only 2.8 percent of those who received synchronous chemoradiation, compared with 5.1 percent among those who received therapy separately. "As much as 2.8 percent reduction in local recurrence rate will have an impact throughout the world. Because if the progression of breast cancer can be prevented then one death can be avoided," said Fernando. (Womens Health Problems)